ZOFIA STEC: Open Payments
NPI 1639567530 · FLORENCE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,058 in 28 payments from 7 companies in 2025. Trend: 2023 $390 · 2024 $349 · 2025 $1,058
Food & beverage: $1,058
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 5 | $272 |
| PFIZER INC. | 7 | $256 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $252 |
| E.R. Squibb & Sons, L.L.C. | 5 | $169 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Abbott Laboratories | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $30 |
Products named: VYNDAQEL, LifeVest, CAMZYOS, AMVUTTRA, WAINUA, CARDIOMEMS, Kerendia, ELIQUIS.
Industry payments across MA — which companies pay providers there.
